Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1301 - 1325 of 3422 in total
Venetoclax is a BCL-2 inhibitor that was initially approved by the FDA in April 2016 [FDA label]. Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are important regulators of the apoptotic (programmed cell death) process , . Venetoclax is used to treat chronic lymphocytic leukemia (CLL) and certain types...
Approved
Investigational
Matched Description: … Venetoclax is approximately 10 times more potent than navitoclax with regard to induction of apoptosis …
Matched Products: … VENCLYXTO 10 MG FILM KAPLI TABLET, 10 ADET ... เว็นเคล็กซ์ต้า 10 มิลลิกรัม ... VENCLYXTO 10 MG FILM KAPLI TABLET, 14 ADET …
A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium, such as the aqueous humor, and is used therapeutically as a diagnostic aid in corneal injuries and corneal trauma. It has been approved by FDA for use in externally applied drugs...
Approved
Matched Products: … FLUORESCEINA SODICA 10% ... FLUORESCEINA SODICA 10%. ... Fluorescite Injection 10% …
Clomipramine, the 3-chloro analog of imipramine, is a dibenzazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, clomipramine does not affect mood or arousal, but may cause sedation. In depressed individuals,...
Approved
Investigational
Vet approved
Matched Products: … ไอนาริล 10 ... Anafranil 10 mg - Dragees ... Clomipramine-10 - Tab 10mg …
A barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
Approved
Investigational
Matched Mixtures name: … NORAL F SUPPOZİTUVAR 10 ADET ... PARANOX 120+15 MG 10 SUPOZİTUAR ... NORAL F FORTE SUPPOZİTUVAR 10 ADET …
Matched Products: … FENOBARBITAL 10 MG TABLETAS ... PHENOBARBITONE TABLET 10 mg ... FENOBARBITAL TABLETAS X 10 MG …
A benzodiazepine derivative used as an anticonvulsant and hypnotic.
Approved
Matched Products: … Nitrazepam-10 ... NITRAZEPAM AL 10 ... NITRAZEPAM-NEURAX 10 MG …
Oxiconazole is an antifungal agent that is commonly found in topical formulations. It is marketed under the brand names Oxistat and Oxistat, and is used in the treatment of various skin infections such as athlete's foot, jock itch and ringworm.
Approved
Matched Products: … OCERAL %1 KREM, 10 G ... OXEZOLE %1 KREM, 10 G ... ZOLEXOL % 1 KREM, 10 G …
Oxazepam is an intermediate-acting, 3-hydroxybenzodiazepine used in the treatment of alcohol withdrawal and anxiety disorders. Oxazepam, like related 3-hydroxybenzodiazepine lorazepam, is considered less susceptible to pharmacokinetic variability based on patient-specific factors (e.g. age, liver disease) - this feature is advantageous as compared to other benzodiazepines, and is likely owing in...
Approved
Matched Products: … PRAXITEN 10 ... OXAZEPAM AL 10 ... OXAZEPAM STADA 10
A vitamin-like antioxidant.
Approved
Investigational
Nutraceutical
Matched Mixtures name: … Medi-10
Matched Products: … NEWOXA 600 MG/50 ML ENJEKSİYONLUK ÇÖZELTİ , 10 FLAKON+10 UYGULAMA SETİ ... NİSİ-L 600 MG/50 ML ENJEKSİYONLUK ÇÖZELTİ , 10 FLAKON + 10 UYGULAMA SETİ ... INSULIPON 600 MG/50 ML ENJEKSIYONLUK ÇÖZELTI IÇEREN FLAKON, 10 FLAKON + 10 UYGULAMA SETI …
Ramucirumab is a human monoclonal antibody (IgG1) against vascular endothelial growth factor receptor 2 (VEGFR2), a type II trans-membrane tyrosine kinase receptor expressed on endothelial cells. By binding to VEGFR2, ramucirumab prevents binding of its ligands (VEGF-A, VEGF-C, and VEGF-D), thereby preventing VEGF-stimulated receptor phosphorylation and downstream ligand-induced proliferation, permeability,...
Approved
Investigational
Matched Products: … CYRAMZA 100MG/10 ML INFÜZYONLUK ÇÖZELTI KONSANTRESI IÇEREN FLAKON, 1 ADET ... CYRAMZA 100MG/10 ML INFÜZYONLUK ÇÖZELTI KONSANTRESI IÇEREN FLAKON, 2 ADET …
Glecaprevir is a direct acting antiviral agent and Hepatitis C virus (HCV) NS3/4A protease inhibitor that targets the the viral RNA replication. In combination with DB13878, glecaprevir is a useful therapy for patients who experienced therapeutic failure from other NS3/4A protease inhibitors. It demonstrates a high genetic barrier against resistance...
Approved
Investigational
Matched Iupac: … {5,10}.0^{18,22}]hentriaconta-3,5(10),6,8,11,14-hexaene-29-carboxamide ... cyclopropyl]-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetraazapentacyclo[26.2.1.0^{3,12}.0^ …
Pemigatinib is a small molecule kinase inhibitor with antitumour activity. It works by inhibiting fibroblast growth factor receptors (FGFRs), which are receptor tyrosine kinases that activate signalling pathways in tumour cells. FGFRs gained attention as potential therapeutic targets in selected cancers, as FGFR gene alterations were observed in a wide...
Approved
Investigational
Carboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma. Early clinical studies of carboplatin were performed in 1982. Carboplatin was developed as an analog of cisplatin with reduced nephrotoxicity and vomiting.[A230463,A230523] Carboplatin was granted FDA approval on 3 March 1989.
Approved
Matched Products: … CARBOPLATINO 10 MG/ML ... CAREZ INJECTION 10 MG/ML ... KEMOCARB INJECTION 10 mg/ml …
Cefotaxime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is considered to be equivalent to ceftriaxone in terms of safety and efficacy. Cefotaxime sodium is marketed under various trade names including Claforan (Sanofi-Aventis).
Approved
Matched Products: … CLAFORAN 2.0 G TOZ+10 CC ÇÖZÜCÜ AMPUL, 1 ADET ... IEFORAN 2 G IV ENJEKTABL TOZ İÇEREN FLAKON, 1 FLAKON+ 10 ML ENJEKSİYONLUK SU İÇEREN AMPUL …
Ciprofloxacin is a second generation fluoroquinolone that has spawned many derivative antibiotics. It is formulated for oral, intravenous, intratympanic, ophthalmic, and otic administration for a number of bacterial infections.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] The first ciprofloxacin containing product was FDA approved on 22 October 1987.
Approved
Investigational
Matched Salts cas: … 86393-32-0 ... 96186-80-0
Matched Mixtures name: … ORCIPOL 500 MG/500 MG FILM TABLET, 10 ADET ... ORNISASIN 500 MG/500 MG FILM TABLET, 10 ADET ... SIPROFORTE 500 MG/ 500 MG FILM TABLET , 10 ADET …
Matched Products: … CIPROLON 250 MG 10 TABLET ... CIPROFLOXACINO100 MG/10 ML ... KINOSIN 250 MG TABLET, 10 ADET …
A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Approved
Matched Iupac: … 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13), …
Matched Products: … DROVID 200 MG FILM TABLET, 10 ADET ... UROSIN 200 MG FILM TABLET, 10 ADET ... FLAXİN %0.3 GÖZ DAMLASI, ÇÖZELTİ, 10 ADET …
Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
Approved
Matched Products: … ETOMIDATE-LIPURO INJECTION 20 mg/10 ml ... HYPNOMIDATE 2 MG /10 ML AMPUL, 5 ADET ... ETOMIDE LIPURO 20MG/10ML IV ENJEKSIYONLUK EMULSIYON ICEREN AMPUL, 10 ADET …
Lacosamide is an antiepileptic drug used to treat seizures. As a chiral functionalized amino acid, it works by blocking slowly inactivating components of voltage-gated sodium currents. Lacosamide exhibits a stereoselective mode of interaction with sodium channels. Lacosamide was first approved by the European Commission in August 2008 and was later...
Approved
Matched Products: … Lacopat 10 mg/ml-Sirup ... BENVIDA 10 MG/ML JARABE ... ELEPSI 10 MG/ML ŞURUP,200 ML ŞIŞE …
Infliximab is a tumor necrosis factor (TNF-alpha or TNF-α) blocker and a chimeric monoclonal IgG1 antibody composed of human constant (75%) and murine variable (25%) regions . Infliximab is produced by a recombinant cell line cultured by continuous perfusion. Tumor necrosis factor-alpha (TNF-α) is a key proinflammatory cytokine involved in...
Approved
Initially approved by the FDA in 1997, quetiapine is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder. Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high...
Approved
Matched Iupac: … 2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl …
Matched Products: … SEROQUEL XR 150 MG UZATILMIŞ SALIMLI TABLET, 10 TABLET …
Ocrelizumab is a CD20-directed cytolytic antibody indicated for the treatment of patients with primary progressive or relapsing forms of multiple sclerosis (MS). It is a second-generation recombinant humanized monoclonal IgG1 antibody that selectively targets B-cells that express the CD20 antigen. Compared to non-humanized CD20 antibodies such as rituximab, ocrelizumab is...
Approved
Investigational
Matched Description: … Primary progressive multiple sclerosis (PPMS) accounts for 10-15% of the overall population of patients …
Matched Products: … OCREVUS 300 MG/10 ML İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 2 ADET ... OCREVUS 300 MG/10 ML İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 1 ADET …
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis. With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and...
Approved
Vet approved
Matched Products: … MELBIK 15 MG TABLET, 10 ADET ... MELBIK 7.5 MG TABLET, 10 ADET ... LOXIDOL 7.5 MG TABLET,10 TABLET …
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.
Approved
Matched Mixtures name: … COFACT 250 IU/10 ML IV ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 1 ADET …
Matched Products: … PROFILNINE FOR INJECTION 1000 iu/10 ml ... PROFILNINE FOR INJECTION 1500 iu/10 ml ... NONAFACT 1000 IU/10 ML IV ENJ. COZ. ICIN LIY.TOZ ICEREN FLAKON …
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
Approved
Matched Products: … DIPIRIDAMOL 10 MG/2ML ... PERSANTIN INJECTION 10 mg/2 ml ... DIPYRIDAMOLE INYECTION USP 10 MG/2ML …
Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular...
Approved
Investigational
Matched Products: … เล็นวิมา (10 มิลลิกรัม) ... LENVIMA HARD CAPSULES 10 MG …
Alendronic acid is a second generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. It functions by preventing resorption of bone[FDA Label] .
Approved
Matched Salts cas: … 129318-43-0
Matched Products: … Alendronate-10 ... ALENDRONATO 10 MG ... LENDO 10 MG TABLET, 28 ADET …
Displaying drugs 1301 - 1325 of 3422 in total